1. Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul08826, Korea
2. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173
Beon-gil, Bundang-gu, Seongnam13620, Korea
3. Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul03722, Korea
4. Research Institute of Radiopharmaceuticals, FutureChem Co. Ltd, Seoul04793, Korea
5. Department of Nuclear Medicine, Heinreich-Heine-University, University Hospital Duesseldorf, Duesseldorf40225, Germany
6. Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) e.v., Bautzner Landstrasse 400, Dresden01328, Germany
7. Technische Universität Dresden, Faculty of Chemistry and Food Chemistry, School of Science, Dresden01069, Germany
8. National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, Dresden01307, Germany
9. German Cancer Consortium (DKTK), Partner Site Dresden, Dresden01307, Germany
10. Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds GmbH, Radeberg1454, Germany
11. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul08826, Korea
12. Advanced Institutes of Convergence Technology, 145 Gwanggyo-ro, Yeongtong-gu, Suwon16229, Korea
13. BIK Therapeutics Inc., 172 Dolma-ro, Bundang-gu, Seongnam13605, Korea